Microbot Medical (MBOT) regains NASDAQ compliance
Tweet
Share
E-mailGet Alerts MBOT Hot Sheet
Join SI Premium – FREE
Microbot Medical (NASDAQ: MBOT) a Delaware-based company specializing in surgical and medical instruments, announced today that it has regained compliance with Nasdaq's minimum bid price requirement. The company received a notification from Nasdaq Stock Market LLC confirming that the minimum closing bid price for Microbot Medical's common stock remained at or above $1.00 per share for 15 consecutive business days, from December 26, 2024, to January 17, 2025.
Create E-mail Alert Related Categories
Corporate News, InvestingRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
